The authors of a Commentary in the November 2020 issue of The American Journal of Managed Care describe the experience of reimagining how a home health program can deliver care amid the coronavirus disease 2019 pandemic.
The coronavirus disease 2019 (COVID-19) pandemic has required health care systems to overhaul their ways of delivering care to patients in order to keep patients, families, and clinicians safe. For medical home visit programs accustomed to visiting patients in person, this task has required creative use of new technologies and relied on regulatory flexibility to facilitate their work.
On this episode of Managed Care Cast, we’re talking with the authors of a Commentary article published in our November issue. The article, “Medical Home Visit Programs During COVID-19 State of Emergency,” describes the experience of reimagining how a home health program can deliver care amid the coronavirus disease 2019 pandemic.
The authors, from Northwell Staten Island University Hospital in Staten Island, New York, are Donna Seminara, MD; Anita Szerszen, MD; John R. Maese, MD; and Zeel Shah, MD.
Listen above or through one of these podcast services:
Read more:
Medical Home Visit Programs During COVID-19 State of Emergency
Ensuring Access to Health Care by FQHCs as States Reopen Amid COVID-19
Could COVID-19 Become a Policy Tipping Point? A Q&A With Kavita K. Patel, MD, MS
Who Should We Treat: Elective Surgical Admissions or Patients With COVID-19?
Hands Down, COVID-19 Will Change Medical Practice
Crisis Into Opportunity: Can COVID-19 Help Set a Path to Improved Health Care Efficiency?
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More